Pharmerging Markets Expected To Keep Sales Growth "Strong" Through 2014, IMS Says
This article was originally published in The Pink Sheet Daily
Executive Summary
IMS forecasts a 5 percent to 8 percent growth of global pharmaceutical sales annually through 2014.
You may also be interested in...
Opportunity Growing For Newer Therapies In Emerging Markets
Big Pharmas seeking to more aggressively grow sales in emerging markets should not underestimate the need for innovative therapies there, specifically antiretrovirals, despite strong sales of generic medicines
Opportunity Growing For Newer Therapies In Emerging Markets
Big Pharmas seeking to more aggressively grow sales in emerging markets should not underestimate the need for innovative therapies there, specifically antiretrovirals, despite strong sales of generic medicines
Abbott Ups Emerging Markets Ante With Zydus Deal, Established Products Unit
The acquisition of Solvay's pharmaceutical unit, completed in February, gave Abbott a substantial branded generics business and strengthened its international presence. Now the company is looking to build on those assets with an enhanced emerging market strategy